Article Information
History
- November 10, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Aaron Switzer, MD1,2,
- Antreas Charidimou, MD, PhD3,
- Stuart J. McCarter, M.D.1,
- Prashanthi Vemuri, PhD4,
- Aivi Nguyen, MD5,
- Scott A. Przybelski6,
- Timothy G. Lesnick6,
- Alejandro A. Rabinstein, MD1,
- Robert D. Brown, MD1,
- David S. Knopman, MD1,
- Ronald C. Petersen, MD, PhD1,
- Clifford R. Jack Jr., MD4,
- R. Ross Reichard, MD5 and
- Jonathan Graff-Radford, MD1,*
- 1Department of Neurology, Mayo Clinic, Rochester, MN, USA
- 2University of Calgary, Calgary, AB, Canada
- 3Department of Neurology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA
- 4Department of Radiology, Mayo Clinic, Rochester, MN, USA
- 5Department of Pathology, Division of Neuropathology, Rochester, MN, USA
- 6Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA
- ↵* Corresponding author; email: graff-radford.jonathan{at}mayo.edu
Posted November 10, 2023.
Boston criteria v2.0 for cerebral amyloid angiopathy without hemorrhage: An MRI-neuropathological validation study
